SMITH, ANDREW
 Distribuzione geografica
Continente #
NA - Nord America 13.794
AS - Asia 10.805
EU - Europa 8.157
SA - Sud America 1.324
Continente sconosciuto - Info sul continente non disponibili 984
AF - Africa 200
OC - Oceania 33
Totale 35.297
Nazione #
US - Stati Uniti d'America 12.979
VN - Vietnam 3.092
IT - Italia 3.091
SG - Singapore 3.070
CN - Cina 2.018
HK - Hong Kong 1.086
BR - Brasile 977
DE - Germania 921
RU - Federazione Russa 865
CA - Canada 669
SE - Svezia 660
IE - Irlanda 646
GB - Regno Unito 429
FR - Francia 327
IN - India 308
AT - Austria 250
BD - Bangladesh 249
UA - Ucraina 192
KR - Corea 167
FI - Finlandia 130
NL - Olanda 127
AR - Argentina 119
ID - Indonesia 114
TR - Turchia 114
ES - Italia 100
IQ - Iraq 99
DK - Danimarca 95
JP - Giappone 81
ZA - Sudafrica 74
MX - Messico 72
CH - Svizzera 70
PL - Polonia 65
EC - Ecuador 56
PK - Pakistan 50
VE - Venezuela 48
PH - Filippine 46
SA - Arabia Saudita 46
CO - Colombia 37
BE - Belgio 35
AU - Australia 32
MY - Malesia 30
IR - Iran 29
PY - Paraguay 29
UZ - Uzbekistan 29
MA - Marocco 26
LT - Lituania 25
TW - Taiwan 22
TN - Tunisia 20
CL - Cile 18
CR - Costa Rica 17
PE - Perù 17
AE - Emirati Arabi Uniti 16
CZ - Repubblica Ceca 16
GR - Grecia 16
JO - Giordania 16
TH - Thailandia 16
EG - Egitto 14
NP - Nepal 14
UY - Uruguay 14
KZ - Kazakistan 13
RO - Romania 13
DZ - Algeria 12
KE - Kenya 12
IL - Israele 11
OM - Oman 11
ET - Etiopia 10
JM - Giamaica 10
NO - Norvegia 10
AZ - Azerbaigian 9
HR - Croazia 9
PT - Portogallo 9
BG - Bulgaria 8
LB - Libano 8
AL - Albania 7
BO - Bolivia 7
DO - Repubblica Dominicana 7
HU - Ungheria 7
KG - Kirghizistan 7
LV - Lettonia 7
PA - Panama 7
PS - Palestinian Territory 7
BY - Bielorussia 6
HN - Honduras 6
RS - Serbia 6
MN - Mongolia 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
GT - Guatemala 4
NI - Nicaragua 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
GA - Gabon 3
KW - Kuwait 3
LY - Libia 3
MU - Mauritius 3
NG - Nigeria 3
PR - Porto Rico 3
Totale 34.267
Città #
Singapore 1.742
Ann Arbor 1.699
Ashburn 1.280
Milan 1.150
San Jose 1.109
Hong Kong 1.046
Ho Chi Minh City 939
Hanoi 725
Dublin 630
Frankfurt am Main 593
Fairfield 585
Chandler 581
Toronto 484
Wilmington 460
New York 410
Woodbridge 365
Houston 348
Santa Clara 348
Los Angeles 323
Dearborn 306
Dallas 278
Seattle 266
Beijing 257
Chicago 226
Vienna 210
Hefei 201
Princeton 193
Cambridge 185
Rome 184
Shanghai 162
The Dalles 162
Jacksonville 153
Seoul 145
Nanjing 135
Buffalo 123
São Paulo 122
Council Bluffs 116
Lauterbourg 115
Dong Ket 111
Da Nang 101
Moscow 93
Columbus 90
Boardman 85
Helsinki 78
Ha Long 73
Haiphong 72
Orem 68
Hải Dương 65
Quận Bình Thạnh 63
Jakarta 62
Kent 61
London 59
Biên Hòa 57
Guangzhou 55
Chennai 53
Turin 51
Brooklyn 50
Montreal 50
Lawrence 49
Tokyo 49
Atlanta 48
Thái Nguyên 48
Nanchang 46
Nuremberg 46
Warsaw 45
Baghdad 44
Denver 43
Munich 43
Vũng Tàu 43
Washington 43
San Diego 42
Altamura 41
Can Tho 41
Lissone 41
Ninh Bình 40
Shenyang 40
Bắc Ninh 38
Manchester 38
Falls Church 37
Johannesburg 36
Sesto San Giovanni 35
Phoenix 34
Poplar 34
Zurich 34
Florence 33
Bắc Giang 32
Fremont 32
Naples 32
Philadelphia 32
Stockholm 32
Basingstoke 31
Changsha 31
Salt Lake City 30
Amsterdam 29
Hebei 29
Ottawa 29
Pune 29
Zhengzhou 29
Andover 28
Quận Một 28
Totale 21.317
Nome #
Viewing coffee fine roots under a molecular lens: Mapping the distribution of relevant metabolites by MALDI-MS imaging 605
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 601
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 567
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 546
3D bioprinted colorectal cancer models based on hyaluronic acid and signalling glycans 492
MALDI mass spectrometry imaging shows a gradual change in the proteome landscape during mouse ovarian folliculogenesis 473
Cytological Cytospin Preparation for the Spatial Proteomics Analysis of Thyroid Nodules Using MALDI-MSI 473
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 460
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 455
The putative role of MALDI-MSI in the study of Membranous Nephropathy 439
Rendering the invisible visible: adding a molecular dimension to pathology with spatial omics 432
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 428
The proteomic landscape of renal tumors 412
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 407
MiralysTM Ambergen. Sequential MALDI-HiPLEX-IHC and untargeted protein imaging to map the tumour-immune environment: academic researcher experience 401
MALDI imaging in Fabry nephropathy: a multicenter study 401
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 398
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 390
Sequential MALDI-HiPLEX-IHC and Untargeted Spatial Proteomics Mass Spectrometry Imaging to Detect Proteomic Alterations Associated with Tumour Infiltrating Lymphocytes 384
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 384
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 384
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 383
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 378
Proteomics for the diagnosis of thyroid lesions: Preliminary report 373
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 367
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 367
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 366
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 361
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 360
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 359
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 359
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 358
Proteomics for the study of new biomarkers in Fabry disease: State of the art 346
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 336
Proteome analysis in thyroid pathology 333
Tumor size, stage and grade alterations of urinary peptidome in RCC 330
The journey towards clinical adoption of MALDI-MS-based imaging proteomics: from current challenges to future expectations 323
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 322
Ion mobility mass spectrometry in the omics era: Challenges and opportunities for metabolomics and lipidomics 318
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 314
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 305
The impact of the non-invasive follicular thyroid neoplasm with papillary-like nuclear feature terminology in the routine diagnosis of thyroid tumours 299
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 296
MALDI-MSI in the study of glomerulonephritis: Possible molecular indicators of CKD progression 290
A molecular imaging approach to individuate tumour infiltrating lymphocytes 290
Intraluminal proteome and peptidome of human urinary extracellular vesicles 289
Exploring 6-aza-2-Thiothymine as a MALDI-MSI Matrix for Spatial Lipidomics of Formalin-Fixed Paraffin-Embedded Clinical Samples 288
Mapping the distribution of bioactive compounds and aroma/flavour precursors in green coffee beans with an integrated mass spectrometry-based approach 282
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 280
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 279
MALDI-MSI analysis of cytological smears: The study of thyroid cancer 278
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 277
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 275
Lipids, proteins, cells: advanced spatial multiomics to delve deeper into the complex molecular and cellular landscape of the tumour microenvironment 264
Machine learning approaches in MALDI-MSI: clinical applications 258
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 255
Thyreoglossal Duct Cyst with Evidence of Solid Cell Nests and Atypical Thyroid Follicles 253
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 253
The role of fine needle aspiration of orbital lesions: A case series 250
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 249
MALDI-MS imaging in the study of glomerulonephritis 249
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 247
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 243
Single-follicle spatial proteomics of the whole ovary by MALDI mass spectrometry imaging: towards the identification of protein-markers of the follicle's quality 243
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 241
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 239
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 239
Incidental Papillary Thyroid Carcinoma: Diagnostic Findings in a Series of 287 Carcinomas 238
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 228
A Mass Spectrometry Imaging-based multiomics approach to map the tumour-immune landscape of clear cell Renal Cell Carcinoma and gain insights into resistance to immunotherapy 226
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 221
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 221
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 215
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 215
Un nuovo approccio basato sull’Imaging con Spettrometria di Massa per la sottotipizzazione dell’amiloidosi renale [A novel mass spectrometry imaging based approach for the subtyping of renal amyloidosisn] 214
What’s brewing? Mapping the distribution of bioactive compounds in green C. arabica coffee beans through MS-driven spatial metabolomics 211
The putative role of MALDI-MSI in the study of Membranous Nephropathy 211
The putative role of MALDI-MSI in the study of Membranous Nephropathy 206
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 205
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 203
Image segmentation with Bayesian mixtures models for multiomics MSI analyses 202
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 201
Single-slide detection and typing of AL renal amyloidosis: combining mass spectrometry imaging and digital pathology 194
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 193
MALDI-MS Imaging in Membranous Nephropathy: from the research to the clinical laboratory? 190
MALDI-MSI analysis of lipid alterations in FFPE patient-derived breast cancer xenograft for pre-clinical and clinical application 190
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 189
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 189
Delving deeper into the Tumour Microenvironment: a MS-driven spatial multiomics approach to provide new molecular insights into immune-tumour cell communication 189
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 186
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 186
Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data 185
High spatial resolution MALDI-MSI in the search for proteomic indicators of response to therapy in Membranous Nephropathy 185
Imaging molecolare a livello cellulare: possiamo predire la risposta alla terapia nella Nefropatia Membranosa? 182
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 179
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 176
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 175
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 170
Does the urinary proteome reflect ccrcc stage and grade progression? 168
Reproducible lipid alterations in patient-derived breast cancer xenograft ffpe tissue identified with maldi msi for pre-clinical and clinical application 164
Totale 29.903
Categoria #
all - tutte 105.548
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.548


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.374 0 144 91 162 114 145 39 83 61 113 149 273
2022/20232.579 300 692 242 199 101 394 47 200 172 37 113 82
2023/20242.140 75 85 82 145 198 585 438 52 132 36 82 230
2024/20255.111 226 452 344 214 439 183 310 196 600 785 567 795
2025/202616.293 2.847 1.521 1.056 1.547 1.540 639 1.987 650 1.050 1.246 1.025 1.185
2026/2027789 561 228 0 0 0 0 0 0 0 0 0 0
Totale 35.297